Education
About Us
Working with TipRanks
Follow Us
Solventum Corporation (SOLV)
NYSE:SOLV
SOLV Stock Chart & Stats
$78.12
-$0.47(-0.68%)
At close: 4:00 PM EST
$78.12
-$0.47(-0.68%)
Day’s Range― - ―
52-Week Range$60.70 - $88.20
Previous CloseN/A
Volume531.14K
Average Volume (3M)883.39K
Market Cap
$13.55B
Enterprise Value$17.04B
Total Cash (Recent Filing)$1.64B
Total Debt (Recent Filing)$5.14B
Price to Earnings (P/E)9.0
Beta0.62
Next Earnings
Feb 26, 2026EPS Estimate
1.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.50
Shares Outstanding173,447,560
10 Day Avg. Volume1,078,609
30 Day Avg. Volume883,394
Financial Highlights & Ratios
PEG Ratio-0.37
Price to Book (P/B)3.87
Price to Sales (P/S)1.39
P/FCF Ratio14.21
Enterprise Value/Market Cap1.26
Enterprise Value/Revenue2.03
Enterprise Value/Gross Profit3.72
Enterprise Value/Ebitda6.57
Forecast
1Y Price Target
$94.38Price Target Upside20.81% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)6.35
Revenue Forecast (FY)$8.03B
Bulls Say, Bears Say
Bulls Say
Capital Allocation / Share RepurchaseA $1 billion share buyback program signals a shift toward shareholder returns and can boost per-share metrics by lowering share count when executed.
Cost Reduction / Margin ImprovementA long-term cost savings initiative targeting roughly $500 million annually is designed to expand operating margins and increase cash flow flexibility for reinvestment and debt reduction.
M&A / Strategic AcquisitionAcera Surgical acquisition broadens the inpatient and regenerative wound-care portfolio with complementary synthetic tissue matrices, supporting higher organic revenue growth and better positioning in surgical markets.
Bears Say
Post-spin Separation RiskOngoing post-spin separation activities carry execution risk that could disrupt operations and create quarterly volatility in reported results.
Share Overhang From Large InvestorA sizable stake held by a legacy investor raises the likelihood of secondary share offerings, which could increase supply and weigh on the stock price.
Tariff-related Earnings HeadwindMaterial tariff-related headwinds, estimated in the tens of millions pre-tax, could reduce adjusted EPS and dampen near-term earnings growth expectations.
Solventum Corporation News
SOLV FAQ
What was Solventum Corporation’s price range in the past 12 months?
Solventum Corporation lowest stock price was $60.70 and its highest was $88.20 in the past 12 months.
What is Solventum Corporation’s market cap?
Solventum Corporation’s market cap is $13.55B.
When is Solventum Corporation’s upcoming earnings report date?
Solventum Corporation’s upcoming earnings report date is Feb 26, 2026 which is in 17 days.
How were Solventum Corporation’s earnings last quarter?
Solventum Corporation released its earnings results on Nov 06, 2025. The company reported $1.5 earnings per share for the quarter, beating the consensus estimate of $1.43 by $0.07.
Is Solventum Corporation overvalued?
According to Wall Street analysts Solventum Corporation’s price is currently Undervalued.
Does Solventum Corporation pay dividends?
Solventum Corporation does not currently pay dividends.
What is Solventum Corporation’s EPS estimate?
Solventum Corporation’s EPS estimate is 1.5.
How many shares outstanding does Solventum Corporation have?
Solventum Corporation has 173,447,560 shares outstanding.
What happened to Solventum Corporation’s price movement after its last earnings report?
Solventum Corporation reported an EPS of $1.5 in its last earnings report, beating expectations of $1.43. Following the earnings report the stock price went up 7.906%.
Which hedge fund is a major shareholder of Solventum Corporation?
Currently, no hedge funds are holding shares in SOLV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Solventum Corporation Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$94.38 (20.81% Upside)
$94.38 (20.81% Upside)
Blogger Sentiment
Bullish
SOLV Sentiment 75%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 3.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.6%
Last 30 Days ▼ 1.6%
Last 30 Days ▼ 1.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.46%
12-Months-Change
Fundamentals
Return on Equity
37.25%
Trailing 12-Months
Asset Growth
-5.24%
Trailing 12-Months
Company Description
Solventum Corporation
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
SOLV Company Deck
SOLV Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Solventum reported strong sales growth, successful portfolio optimization, and a transformed balance sheet, positioning the company for future growth and acquisitions. However, tariff headwinds and segment-specific challenges pose risks. Overall, the highlights significantly outweigh the lowlights, reflecting a positive outlook.View all SOLV earnings summariesSOLV Stock 12 Month Forecast
Average Price Target
$94.38
▲(20.81% Upside)
Technical Analysis
DaVita
―
Fresenius Medical Care
―
Encompass Health
―
Tenet Healthcare
―
Universal Health
―
Ownership Overview
14.88% Insiders
19.36% Mutual Funds
0.61% Other Institutional Investors
44.17% Public Companies and
Individual Investors